Evidence map›Paper›PMID 27401975›Full record

ArticleApplied and environmental microbiology2016

High Level of Spinosad Production in the Heterologous Host Saccharopolyspora erythraea.

Jun Huang, Zhen Yu, Mei-Hong Li, Ji-Dong Wang, Hua Bai, Jun Zhou, Yu-Guo Zheng

Open access · bronzeAbstract read
In one paragraph

Article in Applied and environmental microbiology, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
2.4field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 31 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Increasing the heterologous production of spinosad inSynthetic and systems biotechnology · 2021
    Article
  6. Article
  7. 3 Biotech · 2021
    Review
  8. Article
  9. Engineering the Erythromycin-Producing StrainFrontiers in microbiology · 2020
    Article
  10. Review
  11. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Jun HuangInstitute of Bioengineering, Zhejiang University of Technology, Hangzhou, China Central Research Institute, Zhejiang Hisun Pharmaceutical Co., Ltd., Taizhou, China.
Zhen YuCentral Research Institute, Zhejiang Hisun Pharmaceutical Co., Ltd., Taizhou, China.
Mei-Hong LiCentral Research Institute, Zhejiang Hisun Pharmaceutical Co., Ltd., Taizhou, China.
Ji-Dong WangCentral Research Institute, Zhejiang Hisun Pharmaceutical Co., Ltd., Taizhou, China.
Hua BaiCentral Research Institute, Zhejiang Hisun Pharmaceutical Co., Ltd., Taizhou, China.
Jun ZhouCentral Research Institute, Zhejiang Hisun Pharmaceutical Co., Ltd., Taizhou, China zhoujun@hisunpharm.com zhengyg@zjut.edu.cn.
Yu-Guo ZhengInstitute of Bioengineering, Zhejiang University of Technology, Hangzhou, China zhoujun@hisunpharm.com zhengyg@zjut.edu.cn.
Zhejiang Hisun Pharmaceutical (China) · CNZhejiang University of Technology · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

unlabelledSpinosad, a highly effective insecticide, has an excellent environmental and mammalian toxicological profile. Global market demand for spinosad is huge and growing. However, after much effort, there has been almost no improvement in the spinosad yield from the original producer, Saccharopolyspora spinosa Here, we report the heterologous expression of spinosad using Saccharopolyspora erythraea as a host. The native erythromycin polyketide synthase (PKS) genes in S. erythraea were replaced by the assembled spinosad gene cluster through iterative recombination. The production of spinosad could be detected in the recombinant strains containing the whole biosynthesis gene cluster. Both metabolic engineering and UV mutagenesis were applied to further improve the yield of spinosad. The final strain, AT-ES04PS-3007, which could produce spinosad with a titer of 830 mg/liter, has significant potential in industrial applications. IMPORTANCE: This work provides an innovative and promising way to improve the industrial production of spinosad. At the same time, it also describes a successful method of heterologous expression for target metabolites of interest by replacing large gene clusters.

Indexed as

Cloning, MolecularDrug CombinationsGene ExpressionInsecticidesMacrolidesMetabolic EngineeringMetabolic Networks and PathwaysMultigene FamilySaccharopolysporaDrug CombinationsInsecticidesMacrolidesspinosad

Identifiers

PMID27401975
PMCPMC5007771
OpenAlexW2512674637

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.